Sophoraisoflavone ACAS# 117204-81-6 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 117204-81-6 | SDF | Download SDF |
PubChem ID | 10383349 | Appearance | Powder |
Formula | C20H16O6 | M.Wt | 352.34 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Synonyms | Allolicoisoflavone B | ||
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 5,7-dihydroxy-3-(5-hydroxy-2,2-dimethylchromen-8-yl)chromen-4-one | ||
SMILES | CC1(C=CC2=C(C=CC(=C2O1)C3=COC4=CC(=CC(=C4C3=O)O)O)O)C | ||
Standard InChIKey | RIDRQWKYWXHAOD-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C20H16O6/c1-20(2)6-5-12-14(22)4-3-11(19(12)26-20)13-9-25-16-8-10(21)7-15(23)17(16)18(13)24/h3-9,21-23H,1-2H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Sophoraisoflavone A is an inhibitor of germ tube growth in the AM fungus Gigaspora margarita, it strongly inhibited germ tube growth at 1.25 ug/disc. 2. Sophoraisoflavone A is a potential MRP inhibitor. 3. Sophoraisoflavone A shows inhibitory effects on copper-induced protein oxidative modification of mice brain homogenate in vitro. |
Targets | Antifection |
Sophoraisoflavone A Dilution Calculator
Sophoraisoflavone A Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.8382 mL | 14.1908 mL | 28.3817 mL | 56.7634 mL | 70.9542 mL |
5 mM | 0.5676 mL | 2.8382 mL | 5.6763 mL | 11.3527 mL | 14.1908 mL |
10 mM | 0.2838 mL | 1.4191 mL | 2.8382 mL | 5.6763 mL | 7.0954 mL |
50 mM | 0.0568 mL | 0.2838 mL | 0.5676 mL | 1.1353 mL | 1.4191 mL |
100 mM | 0.0284 mL | 0.1419 mL | 0.2838 mL | 0.5676 mL | 0.7095 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Boc-Ala(3-pyridyl)-OH
Catalog No.:BCC3322
CAS No.:117142-26-4
- Fmoc-N-Me-Thr(tBu)-OH
Catalog No.:BCC3354
CAS No.:117106-20-4
- Fmoc-Thr(tBu)-OPfp
Catalog No.:BCC3553
CAS No.:117088-31-0
- Scutebarbatine C
Catalog No.:BCN2382
CAS No.:910099-75-1
- A 967079
Catalog No.:BCC7967
CAS No.:1170613-55-4
- 3'-Hydroxypuerarin
Catalog No.:BCN2816
CAS No.:117060-54-5
- Combretastatin A4
Catalog No.:BCC7089
CAS No.:117048-59-6
- Wulignan A1
Catalog No.:BCN5808
CAS No.:117047-76-4
- 3'-Methoxypuerarin
Catalog No.:BCN2900
CAS No.:117047-07-1
- Licopyranocoumarin
Catalog No.:BCN7900
CAS No.:117038-80-9
- Anwuweizonic acid
Catalog No.:BCN3633
CAS No.:117020-59-4
- Boc-Asp(Ofm)-OH
Catalog No.:BCC3366
CAS No.:117014-32-1
- M 1145
Catalog No.:BCC6053
CAS No.:1172089-00-7
- PI3Kγ inhibitor 1
Catalog No.:BCC4180
CAS No.:1172118-03-4
- HO-3867
Catalog No.:BCC5639
CAS No.:1172133-28-6
- Taxacin
Catalog No.:BCN6950
CAS No.:117229-54-6
- Soyasaponin Aa
Catalog No.:BCN2597
CAS No.:117230-33-8
- 8alpha-Hydroxylabda-13(16),14-dien-19-yl p-hydroxycinnamate
Catalog No.:BCN1609
CAS No.:117254-98-5
- gamma-secretase modulator 1
Catalog No.:BCC1583
CAS No.:1172637-87-4
- RS 102895 hydrochloride
Catalog No.:BCC7260
CAS No.:1173022-16-6
- STO-609 acetate
Catalog No.:BCC7112
CAS No.:1173022-21-3
- GW 583340 dihydrochloride
Catalog No.:BCC7300
CAS No.:1173023-85-2
- U0126-EtOH
Catalog No.:BCC1066
CAS No.:1173097-76-1
- PKI-402
Catalog No.:BCC3843
CAS No.:1173204-81-3
Lupin pyranoisoflavones inhibiting hyphal development in arbuscular mycorrhizal fungi.[Pubmed:20813384]
Phytochemistry. 2010 Nov;71(16):1865-71.
White lupin (Lupinus albus L.), a non-host plant for arbuscular mycorrhizal (AM) fungi in the typically mycotrophic family Fabaceae, has been investigated for root metabolites that inhibit hyphal development in AM fungi. Four known pyranoisoflavones, licoisoflavone B (1), Sophoraisoflavone A (2), alpinumisoflavone (3) and 3'-hydroxy-4'-O-methylalpinumisoflavone (4), together with three previously unknown pyranoisoflavones, lupindipyranoisoflavone A (5), 10'-hydroxylicoisoflavone B (6) and 10'-hydroxySophoraisoflavone A (7) were isolated from the root exudates of white lupin as an inhibitor of germ tube growth in the AM fungus Gigaspora margarita. Pyranoisoflavones 1, 2 and 3 strongly inhibited germ tube growth at 0.63, 1.25 and 0.63 mug/disc, respectively. The remaining compounds 4-7 were either moderate or weak inhibitors that inhibited germ tube growth at concentrations higher than 10 mug/disc. Licoisoflavone B (1) and Sophoraisoflavone A (2) completely inhibited hyphal branching induced by a lupin strigolactone, orobanchyl acetate, in G. margarita at 0.16 and 0.63 mug/disc, respectively.
Inhibitory effects of licoisoflavones A and B and sophoraisoflavone A of Sophra mooracroftiana Beth ex Baker on copper-ion-induced protein oxidative modification of mice brain homogenate, in vitro.[Pubmed:11554397]
Biol Trace Elem Res. 2001 Aug;81(2):169-75.
We present the results of an in vitro investigation of the inhibitory effects of licoisoflavones A and B and Sophoraisoflavone A isolated from Sophra mooracroftiana BETH ex BAKER on copper-induced protein oxidative modification of mice brain homogenate in vitro. Although inhibitory effect of Sophoraisoflavone A was stronger than those of licoisoflavones A and B, genistein as a related isoflavone, and mannitol as a hydroxy radical scavenger, inhibitory effects of licoisoflavones A and B were weaker than those of genistein and mannitol. These results demonstrated that the difference of inhibitory effects are dependent on the relation between chemical structures of these isoflavones, such as hydroxy group or benzopyran, and oxidative stress.
Monitoring of MRP-like activity in human erythrocytes: inhibitory effect of isoflavones.[Pubmed:11783953]
Blood Cells Mol Dis. 2001 Sep-Oct;27(5):894-900.
A method to fluorometrically monitor efflux of 2',7'-bis-(carboxypropyl)-5(6)-carboxyfluorescein (BCPCF) from human erythrocytes was developed. Genistein, daidzein, Sophoraisoflavone A, and licoisoflavone A induced 50% inhibition (IC(50)) of BCPCF efflux at 15-70 microM. The IC(50) value of the most efficient isoflavone, licoisoflavone A (15-25 microM), was comparable to that of indomethacin (approximately 10 microM) and markedly lower than for probenecid (100-200 microM), both known MRP1 inhibitors. Our results indicate that the human erythrocyte is a useful cell model in screening potential MRP inhibitors, that BCPCF is a good substrate for MRP, and that some isoflavones at low concentrations inhibit MRP-mediated efflux.